CMAC

CMAC is a world-class international hub for manufacturing research and training. Working in partnership with industry, its purpose is to transform current manufacturing processes into the medicine supply chain of the future.

Find out more

CMAC Response to Covid-19

In keeping with the latest government advice, CMAC have resumed lab activities and our collaborative research, training and translation programmes. Find out how CMAC are responding to the global Covid-19 pandemic.

Find out more
Business Case Insights for Continuous Manufacturing

CMAC and PwC are delighted to share ‘The Business Case Insights for Continuous Manufacturing’. This joint document, with input from industrial partners, seeks to review key considerations for building a successful business case for the industrial adoption of innovative Continuous Manufacturing (CM) technologies.

Find out more

Our Vision

CMAC’s vision is to revolutionise the way pharmaceuticals and high value products are made. The approaches developed and adopted within CMAC have been developed through close collaboration with industry and the support of its Tier 1 partners, which includes GlaxoSmithKline, AstraZeneca, Bayer, Lilly, Novartis, Pfizer, Roche and Takeda. Established in 2011, the CMAC has a £150m funding portfolio and currently comprises more than 130 staff and researchers, including academics, post docs, and more than 30 PhD students, as well as an experienced support team.

CMAC

  • conducts world class research in continuous manufacturing and advanced crystallisation;
  • conducts fundamental research;
  • develops new solutions to company specific problems;
  • delivers measurable successes that are of real benefit to society;
  • creates commercial opportunities for start-ups and major global companies;
  • produces a talent pipeline of highly skilled multi-disciplinary staff;
  • influences policy, government, and regulators;
  • understands and integrates with the broader supply chain context
  • collaborates with world class business and academia on an international basis.


 
Research

Industrially relevant research delivered by a multidisciplinary and collaborative academic team

Find out more
Award Winning Facility

Comprehensive suite of continuous processing, process analysis, and characterisation equipment housed in the Technology and Innovation Centre at Strathclyde

Find out more
Training & Skills

A vibrant world-class, multi-disciplinary PhD & MSc training programmes that will equip graduates with leading edge skills in pioneering continuous processes

Find out more
Translation to Industry

The demand-led manufacturing research scope of the Centre was co-created with our industry partners

Find out more

Events

X-ray PDF Applications Scientist (KTP Associate) (411261)
The Continuous Manufacturing and Advanced Crystallisation (CMAC, www.cmac.ac.uk) hub at the University of Strathclyde in partnership with AstraZeneca is seeking to appoint a Knowledge Transfer Partnership (KTP) Associate in the area of X-ray Pair Distribution Function (PDF) analysis. In particular, the role is focussed on the application of PDF to AstraZeneca materials and the focus of the role is on developing approaches for routine sample preparation, laboratory and synchrotron data collection, PDF analysis, reporting and development of training material to enable and support users to implement successfully this powerful analytical method.



AstraZeneca is a leading global biopharmaceutical company with a passion for science (https://www.astrazeneca.com). This includes the application of leading edge analytical methods within development projects to characterise materials This position will be based in AstraZeneca’s Pharmaceutical Research & Development function in Macclesfield.



The post is on a fixed term basis for a period of 24 months with a proposed start date of February 2022. The project is part of the Knowledge Transfer Partnership (KTP) programme that aims to help businesses to improve their competitiveness and productivity through the better use of knowledge, technology and skills that reside within the UK knowledge base. Successful Knowledge Transfer Partnership projects are funded by UK Research and Innovation through Innovate UK and are part of the government’s Industrial Strategy. To find out how KTP works and the vital role you will play if you successfully secure a KTP Associate position please visit: www.ktpws.org.uk.



You will have a PhD in a chemistry, materials science, physics, pharmaceutical science or a related discipline with appropriate experience in a collaborative research environment with knowledge in the area of pharmaceutical materials, X-ray scattering, data analysis and solid form characterisation. Practical experience of working with amorphous materials and in the use of laboratory X-ray and/or synchrotron sources and in the analysis and interpretation of data will be advantageous.



You must have excellent verbal and written communications skills with the ability to write clearly and succinctly. You must also be able to work as a member of a team, as well as demonstrate successful track record of research achievement. You should be able to independently develop new concepts in your research, have excellent organisational skills, initiative, and the ability to pay close attention to details. In addition to the KTP core development training, you will have a dedicated training budget of £4,000 to further support your career development. Location of this role, the Associate will be expected to work mostly at AstraZeneca’s Research & Development Campus in Macclesfield, however will be required to work at the University of Strathclyde for a period of time.



Informal enquiries about the post can be directed to Prof Alastair Florence, (alastair.florence@strath.ac.uk).

Closing Date: 19/12/2021

Formal interviews for this post will be held virtually on 13/01/2022.

Click here for full details.... more

Industry Junior Key Account Manager (413255)


Salary range : £28,756 - £32,344



FTE : 1.0



Term : Fixed (24 months)



Closing date : 19/12/2021







The Continuous Manufacturing and Advanced Crystallisation (CMAC) Hub is a world-class centre of excellence for advanced pharmaceutical manufacturing research and training. As an EPSRC Future Manufacturing Research Hub, led by the University of Strathclyde we work in close collaboration with a number of spokes at leading UK academic institutions (Bath, Cambridge, Imperial College, Leeds, Loughborough, Sheffield) and linking with international centres in the US, Europe and Far East. Working in partnership with industry, CMAC’s purpose is to transform the development and manufacture of medicines through advanced design and manufacturing technologies including the development of Digital Twins and MicroFactories. The four key pillars of CMAC’s program are to: deliver high quality manufacturing research; develop the workforce of the future through skills development and training; to drive effective translation of research into industry and, to continue to develop our world leading facilities and lab of the future infrastructure.





This post offers an exciting opportunity for an experienced administrator/coordinator, ideally with experience in a scientific area. The post holder will be the key contact between CMAC and its industry partners, and will work closely with the Technical Translation Manager and Business Development & Translation Manager, and other senior management to support industry partner engagement with the Centre to develop and sustain long-term relationships.

Responsibilities include: key contact with industry partners (e.g. liaise, collate, and organise key milestones and deliverables, and KPIs), create detailed plans designed to attain predetermined goals and quotas, present and report results and emerging opportunities, design and produce communication material, and provide organisational and administrative support for the CMAC Directors.





The post holder will work with the CMAC industry team on strategic issues relating to development, management and delivery of the Centre’s collaborative programmes with industry partners. They will also co-ordinate meetings and workshops and lead preparation of relevant materials and reports.





Candidates must have excellent IT, communication and interpersonal skills with the ability to organise and prioritise a busy workload using initiative. A relevant technical degree and experience of research administration in a university or company environment is desired. Some travel to events in UK and worldwide is likely with this role.

This is an exciting and challenging position which will provide an ambitious and committed candidate with valuable experience within an International leading Research Centre providing a multi-disciplinary, multi-site university and industry collaborative research environment. Though the position is initially fixed term, there may be opportunity for extension.



Closing Date: 19/12/2021



Formal interviews for this post will be held on 12/01/2022.



Informal enquiries about the post can be directed to Massimo Bresciani, CMAC Industry Director (massimo.bresciani@strath.ac.uk).



Click here for full details.... more

PhD position - Resource-sparing direct compression formulation optimiser to accelerate medicine development
This 4-year PhD project at the University of Strathclyde and in collaboration with GlaxoSmithKline is an excellent opportunity to conduct cutting-edge research at the interface of pharmaceutical manufacturing and data science with the aim of accelerating the development of the next generation of medicines. Your personal development is supported by world-class training opportunities delivered by the Continuous Manufacturing and Advanced Crystallisation Hub (CMAC) and The Data Lab which will put you in an excellent position for your future career in the pharmaceutical industry and beyond.

Information on Application Process

To apply for this project, you should have a background in chemical engineering, chemistry, physics, pharmaceutical science, material science, mechanical engineering, or similar. You will need to have a passion for research, multidisciplinary collaboration, and collaboration with industrial stakeholders.

The offered studentship covers home tuition fees, research/training costs, and provides a stipend for 4 years. Candidates eligible for home fees are UK or Irish nationals, applicants with a settled or pre-settled status in the UK under the EU Settlement Scheme, and applicants with indefinite leave to remain in the UK. We also welcome applications from EU or international candidates who can provide evidence of their ability to fund the fee difference.

Primary Supervisor: Dr Daniel Markl

Additional Supervisor/s: Dr John Robertson, Dr Richard Elkes (GlaxoSmithKline)

Contact Details: Applicants can express their interest for this project or ask any questions by emailing daniel.markl@strath.ac.uk and attaching their CV..... more

News

CMAC Vacancies
CMAC is #hiring! 📢

Do you want to make a difference in the world of #medicinesmanufacturing research? We have some amazing opportunities to join #CMAC, a world leading research centre at the heart of cutting edge innovation.

💊 We are always looking for diverse and inspiring talent
💊 We offer flexible and agile working across our opportunities
💊 We have roles for various skills and career stages

With over 10 vacancies available and more in the pipeline, there has never been a better time to contribute to our broad portfolio of #research, #translation and #skills in award-winning #facilities in #collaboration with global #pharma and technology providers.

.... more

Funding Announcement: Made Smarter Innovation Digital Medicines Manufacturing Research Centre
Funding Announcement: Made Smarter Innovation - Digital Medicines Manufacturing Research Centre







CMAC are delighted to announce a new £5M award from EPSRC to establish and lead the new Made Smarter Innovation - Digital Medicines Manufacturing Research Centre (DM2). This award continues to build CMAC’s research portfolio and is part of the UKRI and Made Smarter Innovation £53 million investment in smart manufacturing and connected supply chain research and innovation. .... more

MIT-CMAC International Symposium on Continuous Manufacturing of Pharmaceuticals
An Integrated Ecosystem for Transforming Medicines Manufacturing





February’s meeting, jointly run between MIT and CMAC Future Manufacturing Research Hub, brought together over 350 pharmaceutical industrialists, regulators, policy makers and academics from more than 22 countries and 142 organisations to inform strategies to grow medicines manufacturing in the UK and internationally, through accelerating the adoption of advanced manufacturing and digital technologies..... more